Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform†
Tae-Lin Ha,Hyo Jin Kim,Jongmin Shin,Geun Ho Im,Jae Won Lee,Hyejung Heo,Jehoon Yang,Choong Mo Kang,Yearn Seong Choe,Jung Hee Lee,In Su Lee
Chemical Communications Pub Date : 07/15/2011 00:00:00 , DOI:10.1039/C1CC12961A
Abstract

A platform protocol developed based on the hollow manganese oxide nanoparticles provided multimodal diagnostic agents, which allow the selectively detect vulva cancer with T1-weighted in vivo MRI.

Graphical abstract: Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform